Women trust pap smears, mammograms, skincare labels, and feminine hygiene products without question. The full risk and ingredient information rarely makes it into the conversation.
I uncover five areas of women's health where transparency is seriously lacking. Gynecological tools are sterilized with a known carcinogen. Cumulative mammogram radiation is seldom mentioned by doctors.
Skincare routines layer over a hundred synthetic compounds onto your skin before breakfast. Chlorine-bleached fibers sit against permeable tissue for days each month during menstruation. And the word "fragrance" legally conceals dozens of undisclosed toxic ingredients on a single label.
This is not about fear. It's about giving women the information to make real decisions. Understanding false positive rates, reading ingredient labels, and reducing chemical burden are practical steps anyone can take today.
Whether you're rethinking your skincare shelf, questioning a screening recommendation, or learning what "fragrance" actually means, this episode fills in what the system leaves out.
TimeStamps:
[00:00] Introduction
[04:32] Ethylene oxide on pap smear instruments and what consent forms leave out
[07:24] How abnormal pap results can trigger a cascade of follow-up procedures
[12:13] Mammogram compression, cumulative radiation, and the over diagnosis problem
[19:58] Why screening campaigns emphasize urgency over diagnostic nuance
[23:14] Endocrine-disrupting chemicals hiding in everyday skincare products
[29:20] Chlorine bleaching and the case for cleaner feminine hygiene products
[35:45] What the word "fragrance" legally conceals on ingredient labels
Resources Mentioned:
Arvoti All Natural Skincare
Hello, and welcome back to the Gubba Homestead Podcast. I'm Gubba, a first time homesteader following in the footsteps of my homesteading forebears. I discuss everything from homesteading to prepping and everything in between. Today we are talking about one of the most protected and rarely challenged areas of modern life: women’s health.
There are certain things women are simply expected to do without question. Schedule the screening. Use the product. Trust the label. Follow the recommendation. Most of the time, women are given a quick summary of benefits, but almost never the deeper story behind the risks, ingredients, long-term exposure concerns, or industry conflicts shaping those recommendations.
And that is what this episode is about.
Because informed consent without full information is not informed consent at all.
Before we get into today’s topic, I want to thank the sponsor of this podcast, which is my small skincare business, Arvoti.
Arvoti began with one tallow balm I made for my dad when he was suffering from eczema, and now it has grown into something that helps thousands of people looking for cleaner, truly nourishing skincare. If you are wanting to upgrade your skincare routine and get away from harsh conventional products, you can explore my small batch made tallow balms, cleansers, serums, and goat milk soaps at Arvoti.
Now let’s get into this.
Today we are diving deep into five things every woman deserves to understand before blindly trusting the systems, products, and procedures that have become normalized in women’s healthcare.
We are talking about pap smears, mammograms, feminine hygiene products, skincare chemicals, and synthetic fragrance.
And I want to be clear from the beginning: this is not fear-based. This is educational. This is about nuance, transparency, and giving women information they are too often denied.
1. The Pap Smear Conversation No One Is Having
What are pap smears actually checking for—and what are women not being told?
Pap smears have become so normalized in women’s healthcare that most women never pause to question what is actually happening during the procedure, what materials are involved, or what information is being left out of the conversation. For many women, the pap smear is introduced as a routine milestone of adulthood, placed on the same checklist as annual exams and bloodwork, presented with the reassuring language of prevention and standard care.
It is framed as simple, necessary, and unquestionably beneficial, and to be fair, cervical screening has absolutely played a significant role in reducing cervical cancer deaths through early detection of abnormal cellular changes. That benefit should not be minimized. Detecting precancerous lesions before they progress can, in some cases, prevent invasive disease and save lives.
Are pap smear tools sterilized with carcinogenic chemicals?
What is often missing, however, is any meaningful discussion about the mechanics behind the procedure itself, especially the materials and sterilization systems involved in the tools used during gynecologic exams. Women are typically told what the pap smear is looking for, but not what the instruments used to collect those samples may have been exposed to before entering the exam room.
Disposable speculums, cervical brushes, and collection devices are frequently manufactured from plastic polymers that cannot withstand high heat sterilization, which is why many of them are sterilized using ethylene oxide gas.
Ethylene oxide is widely used in the medical industry because we are told it is highly effective at penetrating packaging and killing bacteria, viruses, and fungi on delicate heat-sensitive instruments. Yet ethylene oxide is not a benign substance.
It has been classified by the Environmental Protection Agency, the World Health Organization, and multiple toxicological agencies as a carcinogen due to its established links to cancer risk in occupational exposure settings.
That distinction matters.
Why aren’t women informed about sterilization methods in medical procedures?
The fact that ethylene oxide is used in sterilization does not automatically make every sterilized medical device dangerous, but it does raise a serious question about disclosure.
Women are almost never informed whether the instruments used in their pap smear were sterilized using ethylene oxide, what residual levels may remain after sterilization, how those levels are tested, or what safety thresholds regulators deem acceptable.
Those thresholds exist, but they are determined by regulatory risk models that most patients never see, never hear explained, and are never invited to question.
In any other setting, if a known carcinogenic compound were involved anywhere in the chain of exposure to an internal medical procedure, most people would assume that fact would at least be mentioned in the consent process.
If women are expected to sign consent forms for procedures, why are they never told when carcinogenic sterilization chemicals are part of the equation?
That is not a rejection of medicine. That is a demand for transparency.
What happens after an abnormal pap smear result?
And the discussion becomes even more layered when one looks beyond the instrument itself and into the downstream consequences of abnormal findings.
Pap smears are screening tools, not diagnostic tools, which means they identify suspicious cellular changes that may require further investigation. The problem is that screening tests inevitably create gray areas.
Mild abnormalities can resolve spontaneously, especially in younger women, because many cervical cell changes can clear up naturally without intervention. Yet once an abnormal pap result enters a medical chart, it can trigger a cascade of follow-up procedures.
These interventions are not insignificant.
For example, removing abnormal cervical tissue using a heated wire loop, and while they are often medically appropriate, they are not consequence-free.
Research has shown associations between cervical excisional procedures and increased risks of cervical insufficiency, preterm birth, and complications in future pregnancies depending on how much tissue is removed.
For women who are never told that possibility before agreeing to follow-up treatment, the emotional impact can be profound. The language surrounding abnormal pap results is often clinical and detached, yet for the woman receiving the phone call, it may mean days or weeks of fear, anxiety, and uncertainty before she even knows whether the abnormality is truly dangerous.
False positives are another rarely discussed issue. Not every abnormal pap smear indicates cancer, or even precancer. Inflammation, transient viral changes, benign infections, hormonal fluctuations, and sampling irregularities can all affect results.
Yet many women are ushered into additional invasive testing without ever being given a clear understanding of how common spontaneous regression can be in certain categories of abnormal cervical findings.
This is where informed consent becomes more than a signature on a clipboard.
True informed consent requires that women understand not only the benefit they tell us—that pap smears can catch dangerous changes early—but also the limitations, the false-positive rates, the potential for overtreatment, the materials used in the exam, and the implications of each subsequent intervention.
It requires physicians to explain not simply that a pap smear is recommended, but why, how often, under what circumstances, and with what tradeoffs.
Women are still treated under broad one-size-fits-all protocols that fail to acknowledge that personalized medicine should apply to preventive care as much as it does to treatment. That's just where we are at with medicine, sadly.
The point is that women deserve to be treated as intelligent participants in their healthcare rather than passive recipients of standardized procedures.
A woman has every right to ask what materials are being used, how instruments are sterilized, whether alternatives exist, what her actual risk profile is, what the false-positive rate may be, and what the long-term implications are if an abnormal result leads to intervention.
Some would say pap smears remain a valuable tool in women’s health, but value does not excuse opacity. Preventive medicine should never rely on blind trust alone. A procedure can be beneficial and still deserve scrutiny. I'm just here to give you the big picture.
And that is the conversation women should have been invited into all along.
2. Mammograms: Screening Tool or Mechanical Trauma?
Mammograms occupy a uniquely protected space in modern women’s healthcare, largely because they are framed not merely as a screening option, but as a moral obligation. For decades, public health messaging has conditioned women to associate mammography with responsibility, vigilance, and survival.
The narrative is simple and emotionally powerful: early detection saves lives, therefore routine mammograms are presented as an unquestionable good. And there is truth in that.
Mammography has undeniably helped identify breast cancers at earlier stages, and in many cases early detection can improve treatment options, reduce disease progression, and improve long-term outcomes. For certain women, mammograms have absolutely been life-saving.
But what is often absent from the public conversation is a serious, balanced examination of the physical, biological, and diagnostic complexities surrounding mammography itself.
At its core, mammography is a radiologic imaging technique that requires the breast to be compressed between two rigid plates in order to flatten tissue and obtain clear X-ray images.
The reason for compression is practical from an imaging standpoint: flattening reduces tissue overlap, improves image clarity, and lowers the radiation dose required to produce diagnostic images. That is the official rationale. Yet what is presented as a technical necessity can feel, for many women, physically invasive and deeply uncomfortable.
For women with dense breast tissue, fibrocystic breasts, implants, scar tissue, inflamed lymphatic congestion, tenderness linked to hormonal cycles, or existing cysts, the compression can be intensely painful.
This is not a rare complaint. It is one of the most common experiences women report after mammography, yet pain is often minimized as though discomfort is an inconsequential tradeoff rather than a legitimate factor worthy of medical discussion.
The more controversial question, however, is whether the compression itself can create mechanical stress on vulnerable breast tissue in ways that deserve more scrutiny than they currently receive.
Some clinicians and critics have raised concerns that forceful compression may rupture fluid-filled cysts, aggravate inflamed tissue, compress sensitive lymphatic pathways, or traumatize already compromised breast structures.
In women with fibrocystic changes, where breast tissue may already contain multiple painful nodules or cystic pockets, the concern is not theoretical from the patient perspective. Many women report post-mammogram soreness lasting hours or days, and in some cases describe inflammatory flare-ups after imaging.
Mainstream radiology organizations maintain that mammograms are generally safe and that compression-related harm is minimal. Yet the reality is that very little public-facing discussion explores whether repeated annual mechanical compression of delicate glandular tissue has subtle long-term implications, particularly in women whose breasts are already structurally vulnerable.
When a screening test requires crushing living tissue between metal plates, women deserve more than a slogan and pink ribbon, they deserve a full explanation of the tradeoffs.
That statement may sound provocative, but it points to a deeper issue: medicine often frames discomfort as acceptable without fully exploring whether all patients bear that burden equally.
Then there is the radiation question, which is rarely discussed with nuance.
Mammograms use low-dose ionizing radiation, and while each individual scan exposes a woman to only a relatively small amount, radiation exposure is cumulative over a lifetime.
A single mammogram may be considered low risk, but a woman who begins annual screenings in her forties and continues into her seventies may accumulate decades of repeated ionizing exposure concentrated in radiosensitive breast tissue.
Radiologists emphasize that the benefits outweigh the risks in most screening populations, and that statement may be true in many cases, but the phrase “low dose” should never be mistaken for “no consequence.” Ionizing radiation, by definition, has the ability to alter cellular DNA.
The risk may be statistically small, but it is not nonexistent, and women deserve to understand that distinction rather than being reassured with vague language that glosses over the biological reality.
Another major issue in mammography that is profoundly under-discussed is overdiagnosis.
Overdiagnosis occurs when mammograms detect abnormalities that technically meet criteria for cancer or precancer but would never have become life-threatening during a woman’s lifetime.
This is one of the most difficult realities in cancer screening because once an abnormality is found, neither patient nor physician can easily predict with certainty which lesions will progress aggressively and which may remain indolent.
As a result, women may undergo biopsies, lumpectomies, mastectomies, radiation, or hormonal therapies for lesions that might never have harmed them.
This creates a paradox in breast screening medicine: some women are saved by early detection, while others are subjected to invasive treatment for findings that may never have posed real danger.
That distinction matters enormously, because overtreatment is not benign. Biopsies carry procedural risks. Surgeries alter tissue permanently. Radiation has systemic effects. Hormonal therapies may create years of side effects including bone loss, fatigue, hot flashes, cardiovascular strain, and emotional distress.
Yet the public narrative around mammography rarely acknowledges this complexity. Screening campaigns tend to emphasize emotional urgency rather than diagnostic nuance, leaving women with the impression that every detected abnormality represents an imminent life-threatening emergency, when in reality breast pathology is often far more complicated.
Alternative and adjunctive screening methods deserve far more public discussion than they currently receive.
Thermography, though controversial and not accepted as a standalone replacement in conventional oncology, is explored by some women seeking non-radiation monitoring. The issue is not that one method is universally superior.
The issue is that women deserve individualized screening strategies rather than blanket protocols based solely on age brackets and generalized recommendations.
None of this is to say mammograms have no value. They do for some people.
We are told that mammograms can detect dangerous tumors before they are palpable. They can identify suspicious calcifications invisible to touch. They can provide critical early warnings that change outcomes for women facing aggressive disease.
You know, all of these things they are told that mammagrams do based on the current medical system we operate under. So you get to decide for yourself.
But benefit does not erase complexity.
A woman should never be pressured into mammography through fear alone, nor should she be shamed for asking hard questions about compression trauma, radiation burden, false positives, dense tissue limitations, or alternative imaging options.
“Early detection is meaningful, but women should not have to surrender informed consent in exchange for access to it.” That is the heart of this conversation. The real issue is not whether mammograms are good or bad. The real issue is whether women are being given full-spectrum information before they agree to them.
Because true preventive care is not built on blind compliance. It is built on knowledge, context, transparency, and the right of every woman to make medical decisions with her eyes fully open.
And you don't even have to be in a medical setting to be making better choices, you can also be making better choices at the store when it comes to skincare, feminie hygiene products, and perfumes. They really think they got us, but I'm going to break it all down for you, so you know what you're getting into next time you are in the store.
3. Skincare: The Daily Hormone Disruptor Hidden in Plain Sight
Modern skincare is marketed as self-care, wellness, beauty, confidence, anti-aging, and empowerment, yet behind the polished packaging and luxury branding lies an industry built on chemical complexity that most women are never taught how to decode.
The average woman applies multiple personal care products every single day—cleanser, toner, moisturizer, serum, sunscreen, makeup primer, foundation, body lotion, deodorant, shampoo, conditioner, styling creams, perfumes, lip products, and hand creams—often before leaving the house in the morning.
By the end of one day, a woman may have layered well over a hundred chemical compounds onto her skin without ever realizing it.
What makes this especially significant is that skin is not an inert wrapper.
Skin is a living organ—vascular, metabolically active, and partially absorptive. While not every ingredient penetrates deeply, many compounds can and do enter through the epidermal barrier, especially when applied repeatedly, on thin skin, over large surface areas, or in formulations specifically designed to enhance penetration. This is where endocrine-disrupting chemicals enter the conversation.
Many conventional skincare and cosmetic products contain ingredients that have raised concerns in hormone and fertility research, including parabens, phthalates, formaldehyde-releasing preservatives, oxybenzone, PEG compounds, triclosan in some antimicrobial formulations, and synthetic fragrance blends.
Parabens are widely used preservatives because they prevent microbial contamination and extend shelf life, but their structural similarity to estrogen has made them controversial. Studies have demonstrated that parabens can exhibit weak estrogenic activity, meaning they may mimic estrogen behavior in the body under certain conditions.
Parabens have also been detected in human breast tissue samples, which has intensified public concern, even though the interpretation of those findings remains debated in mainstream medicine.
Phthalates, often hidden inside fragrance formulations, are another major concern because they interfere with hormone signaling pathways. Research has associated phthalate exposure with reproductive dysfunction, altered estrogen and testosterone balance, ovarian disruption, and impaired fertility markers in both women and men.
Oxybenzone, commonly found in chemical sunscreens, has been shown in studies to undergo systemic absorption after topical application. Researchers have detected measurable oxybenzone levels in blood and urine after sunscreen use, raising legitimate questions about long-term hormonal implications, especially when exposure begins in childhood and continues for decades.
The larger issue, however, is not any one chemical in isolation. The real concern is cumulative burden. I speak about this all the time online, same thing goes with eating food as well and that's why it drives me nuts when people say everything in moderation. Like no, a poison is still poison in moderation.
A woman may use a moisturizer with parabens, sunscreen with oxybenzone, perfume containing phthalates, shampoo with fragrance compounds, and foundation with PEG emulsifiers, all before breakfast.
Regulatory systems often assess safety ingredient by ingredient, yet the female body is not exposed ingredient by ingredient. It experiences them as layered mixtures, interacting simultaneously in complex biological systems.
Your skincare shelf may be the most overlooked endocrine experiment in your home, and most women have no idea they are participating in it every morning. That is precisely why ingredient literacy matters.
For women dealing with infertility, irregular cycles, estrogen dominance, PCOS, thyroid dysfunction, unexplained migraines, chronic inflammation, or persistent hormonal imbalance, environmental toxic load may be one overlooked contributing factor among many.
Not every hormone issue is caused by product exposure, but ignoring chemical burden as a possible influence is increasingly difficult to justify.
This is deeply personal to me, and it is why I created Arvoti.
When I started Arvoti, my goal was not simply to make skincare products, it was to strip skincare back to formulations rooted in nourishment rather than chemical overload. I wanted products built around ingredients the skin recognizes and can work with, rather than synthetic cocktails designed more for shelf stability, scent profile, and marketing claims than long-term physiological harmony.
Real skincare should strengthen the skin barrier, support repair, replenish lipids, and protect without forcing women to absorb unnecessary synthetic additives disguised as sophistication.
Luxury has convinced women that more ingredients means better skincare. Often the opposite is true. Sometimes the most protective skincare is the simplest, the formulations with fewer unnecessary chemicals, fewer endocrine disruptors, fewer hidden fragrance blends, and fewer compounds that the body must process without ever having asked for them.
Choosing cleaner skincare is not a trend. It is a long-term investment in reducing unnecessary chemical burden in a world already saturated with exposure.
4. Feminine Products and the Chemical Burden Women Carry Monthly
Few categories of consumer products are as underexamined, and yet as intimately used—as feminine hygiene products. Tampons, pads, pantyliners, wipes, sprays, washes, deodorizing mists, and scented “feminine care” products are marketed as ordinary necessities, tucked into pharmacy aisles under pastel packaging and reassuring language about cleanliness, comfort, and freshness.
Most women begin using these products in adolescence and continue using them month after month, year after year, for decades, often without ever being told what is actually in them or how those ingredients interact with the body.
This lack of scrutiny is especially striking when one considers where these products are used.
These tissues are among the most permeable and vascularized tissues in the human body. Unlike the thicker keratinized skin on arms or legs, mucosal tissues are thinner, more absorptive, and designed biologically for transfer and exchange.
This means that substances placed in prolonged contact with these tissues may be absorbed into circulation more readily than ingredients applied elsewhere on the body. That physiological fact alone should demand a far higher standard of ingredient transparency than most feminine care companies currently provide.
Yet many conventional menstrual and feminine hygiene products contain a complex mixture of industrial materials that few women would knowingly choose if presented plainly.
These often include chlorine-bleached rayon or cotton fibers, synthetic fragrance blends, adhesives used in pad backings, polyethylene plastic layers, superabsorbent chemical gels, petroleum-derived liners, dyes, and preservative agents.
While each of these ingredients may individually fall within regulatory safety limits, what remains poorly understood is the cumulative burden created by repeated exposure over decades in real-life use patterns.
One of the most debated issues is chlorine bleaching.
Many tampons and pads are processed using bleaching methods that historically raised concern over dioxin byproducts.
Dioxins are persistent environmental pollutants that have been studied for links to endocrine disruption, reproductive toxicity, immune dysfunction, and carcinogenicity at certain exposure levels. Manufacturers and regulators often emphasize that modern bleaching techniques produce only trace amounts and that current dioxin residues in finished products are extremely low.
That may be true according to laboratory thresholds, but low-level exposure repeated monthly over thirty or forty years is not the same as isolated exposure.
That distinction matters profoundly.
Toxicology often evaluates substances in singular, controlled conditions, yet women do not live in laboratories. They live in cumulative chemical environments.
A woman may use tampons or pads for five days every month, for forty years, while simultaneously being exposed to endocrine-disrupting compounds from cosmetics, food packaging, plastics, detergents, and air fresheners.
The interaction of those layered exposures is one of the least understood aspects of women’s environmental health.
The feminine hygiene market has, in many ways, normalized chemical interference in one of the body’s most self-regulating systems.
Healthier alternatives exist, but they are often under-promoted because they are less profitable than recurring scented disposable products. Unscented organic cotton tampons and pads reduce unnecessary fragrance exposure.
Medical-grade silicone menstrual cups eliminate repeated fiber contact and reduce waste. Reusable cloth pads avoid plastic layers and adhesives. Fragrance-free external cleansing with warm water is often physiologically sufficient for daily hygiene.
Women deserve to know that much of what is sold as feminine freshness is not medically necessary. It is branding layered over chemical exposure.
And when something touches the most permeable tissues in the body month after month for decades, “good enough” ingredient standards are not good enough.
5. Fragrance: The Silent Toxin in Nearly Everything
If there is one ingredient category that may be the most underestimated, under-regulated, and misunderstood in women’s health, it is synthetic fragrance. Few consumers realize how deeply fragrance has infiltrated daily life because it no longer exists only in perfume bottles.
It is embedded into lotions, shampoos, detergents, dryer sheets, deodorants, candles, cosmetics, facial creams, baby wipes, feminine products, household cleaners, hand soaps, hair sprays, and even products marketed as “unscented,” which may still contain masking fragrance compounds.
The word fragrance sounds harmless, almost elegant. But on an ingredient label, it is often one of the least transparent terms in the entire product.
Under trade secret protections, manufacturers are legally permitted to list “fragrance” as a single umbrella term while concealing dozens or hundreds of proprietary chemicals contained within that blend.
Consumers are rarely told which specific compounds are included, even when some of them may be allergens, respiratory irritants, endocrine disruptors, or compounds linked to reproductive toxicity.
This means a single word on a label may hide phthalates, volatile organic compounds, aldehydes, synthetic musks, benzene derivatives, terpenes, solvents, and sensitizing preservatives, all without itemized disclosure.
That opacity should concern every woman.
Phthalates are particularly alarming because they are commonly used in fragrance formulations to help scents linger longer on skin and fabrics. Yet phthalates are among the most studied endocrine disruptors in environmental health science.
They have been associated with altered estrogen and androgen signaling, menstrual irregularities, ovarian dysfunction, fertility impairment, pregnancy complications, and developmental reproductive abnormalities in offspring when exposure occurs during pregnancy.
Fragrance is not merely smelled. It is inhaled into the lungs, absorbed through skin, dissolved into mucous membranes, and dispersed into indoor air where it lingers in enclosed spaces.
That innocent word ‘fragrance’ may be the most chemically deceptive label in your home, and women are marinating in it from morning until night.
Respiratory consequences are another major concern.
Synthetic fragrance compounds have been linked to headaches, migraines, asthma aggravation, sinus irritation, chronic coughing, wheezing, dizziness, and sensory sensitivity reactions. Many women who believe they are reacting to “strong smells” are actually experiencing physiological responses to airborne chemical compounds rather than scent intensity alone.
What makes fragrance uniquely problematic is that exposure is nearly impossible to avoid unless a woman makes deliberate lifestyle changes.
A woman may avoid perfume personally and still be exposed through scented laundry detergent on clothing, fragranced office air fresheners, candles in public buildings, perfumes worn by others, salon products, and fragranced cleaning chemicals used in shared environments.
And because hormone systems operate on delicate signaling pathways, even low-dose repeated exposure may matter more than people realize.
The endocrine system is not designed to process synthetic fragrance chemicals as biologically meaningful inputs, yet many fragrance compounds mimic, block, or interfere with hormone signaling in ways researchers are still unraveling.
Women are particularly vulnerable because hormonal rhythms are central to reproductive health, fertility, menstrual cycling, thyroid regulation, mood balance, metabolic stability, and pregnancy outcomes. Even subtle disruption in endocrine communication can create cascading effects over time.
This is why unscented products should not be seen as plain, dull, or inferior. Unscented often means fewer hidden chemicals, fewer undisclosed phthalates, fewer respiratory irritants, and fewer unnecessary exposures layered into daily life.
Natural scent from whole essential oils, when used carefully and transparently disclosed, is not the same as synthetic fragrance blends engineered in laboratories from undisclosed petrochemical derivatives.
Fragrance has been sold to women as beauty, femininity, freshness, comfort, and luxury.
But behind that marketing language lies one of the most chemically opaque industries in modern consumer life. And the more women understand that, the more power they regain over what they allow into their homes, onto their skin, and into their bodies.
